Cargando…

Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing

The World Health Organization (WHO) has called for the elimination of cervical cancer as a public health problem. Cervical cancer screening through human papillomavirus (HPV) testing is a core component of the strategy for elimination, with a set target of screening 70% of women twice in their lifet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kundrod, Kathryn A., Jeronimo, Jose, Vetter, Beatrice, Maza, Mauricio, Murenzi, Gad, Phoolcharoen, Natacha, Castle, Philip E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431663/ https://www.ncbi.nlm.nih.gov/pubmed/37585432 http://dx.doi.org/10.1371/journal.pgph.0001982

Ejemplares similares

Preliminary Xpert® HPV testing results from a large study of women living with HIV in Rwanda
por: Murenzi, Gad
Publicado: (2019)

Type-specific persistence, clearance and incidence of high-risk HPV among screen-positive Rwandan women living with HIV
por: Murenzi, Gad, et al.
Publicado: (2021)

Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol
por: Murenzi, Gad, et al.
Publicado: (2022)

Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With Men
por: Murenzi, Gad, et al.
Publicado: (2020)

Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
por: Kantathavorn, Nuttavut, et al.
Publicado: (2015)

Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda
por: Murangwa, Anthere, et al.
Publicado: (2022)

A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand
por: Phoolcharoen, Natacha, et al.
Publicado: (2017)

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
por: Gallagher, Katherine E., et al.
Publicado: (2017)

A low-cost, paper-based hybrid capture assay to detect high-risk HPV DNA for cervical cancer screening in low-resource settings
por: Smith, Chelsey A., et al.
Publicado: (2022)

A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care
por: Chang, Megan M., et al.
Publicado: (2023)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador
por: Cremer, Miriam, et al.
Publicado: (2017)

HPV vaccines for circumpolar health: summary of plenary session, “Opportunities for Prevention: Global HPV Vaccine” and “Human Papillomavirus Prevention: The Nordic Experience”
por: Dunne, Eileen F., et al.
Publicado: (2013)

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
por: Jemal, Ahmedin, et al.
Publicado: (2013)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
por: Engesæter, Birgit, et al.
Publicado: (2016)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

Vaccination coverage against human papillomavirus (HPV) and associated factors in female academics from a university in southwestern Goiás, Brazil
por: de Oliveira, Paulo Sérgio, et al.
Publicado: (2021)

Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?
por: Waheed, Dur-E-Nayab, et al.
Publicado: (2023)

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
por: Campos, Nicole G., et al.
Publicado: (2019)

Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda
por: Sinayobye, Jean d’Amour, et al.
Publicado: (2014)

Agreement of self- and physician-collected samples for detection of high-risk human papillomavirus infections in women attending a colposcopy clinic in Thailand
por: Phoolcharoen, Natacha, et al.
Publicado: (2018)

HPV Serology Testing Confirms High HPV Immunisation Coverage in England
por: Mesher, David, et al.
Publicado: (2016)

A pharmacist’s guide to human papillomavirus (HPV)
por: Cable, Cheryl E., et al.
Publicado: (2022)

Recent Developments in Human Papillomavirus (HPV) Vaccinology
por: Williamson, Anna-Lise
Publicado: (2023)

Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151
por: Kovanda, Anja, et al.
Publicado: (2011)

Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination
por: Suppli, Camilla Hiul, et al.
Publicado: (2018)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea
por: Park, Eunhyang, et al.
Publicado: (2019)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Human Papillomavirus (HPV) Health Savings as an Alternative Solution: HPV Vaccination Behavior in Adolescents
por: Lismidiati, Wiwin, et al.
Publicado: (2021)

hpvPDB: An Online Proteome Reserve for Human Papillomavirus
por: Kumar, Satish, et al.
Publicado: (2013)

Co-occurrence of human papillomavirus (HPV) in newborns and their parents
por: Skoczyński, Mariusz, et al.
Publicado: (2019)

An unusual presentation of an oral human papillomavirus (HPV) lesion
por: Casu, Cinzia, et al.
Publicado: (2020)

Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx
por: Castro, Therezita Peixoto Patury Galvão, et al.
Publicado: (2015)

Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
por: Manolescu, Loredana Sabina Cornelia, et al.
Publicado: (2022)

The genetic diversity of human papillomavirus types from the species Gammapapillomavirus 15: HPV135, HPV146, and HPV179
por: Hošnjak, Lea, et al.
Publicado: (2021)

Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland
por: McCusker, Sarah M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a450kp5afk07pj18l4mmbpjpj0